UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 95

Sortiert nach

Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma

Journal of translational medicine, 2024-06, Vol.22 (1), p.556-17, Article 556

2024

Volltextzugriff (PDF)

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors

Oncogene, 2018-08, Vol.37 (33), p.4611-4625

2018

Volltextzugriff (PDF)

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer

BMC medicine, 2017-06, Vol.15 (1), p.116-116, Article 116

2017

Volltextzugriff (PDF)

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene

PloS one, 2020-07, Vol.15 (7), p.e0235766

2020

Volltextzugriff (PDF)

Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer

PloS one, 2016-10, Vol.11 (10), p.e0165385-e0165385

2016

Volltextzugriff (PDF)

Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways

Genome medicine, 2016-10, Vol.8 (1), p.107-107, Article 107

2016

Volltextzugriff (PDF)

Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression

PloS one, 2013-09, Vol.8 (9), p.e70878

2013

Volltextzugriff (PDF)

Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer

Clinical cancer research, 2009-12, Vol.15 (23), p.7389-7397

2009

Volltextzugriff (PDF)

Genome-wide promoter analysis uncovers portions of the cancer methylome

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (8), p.2661-2670

2008

Volltextzugriff (PDF)

Prognostic Cell Biological Markers in Cervical Cancer Patients Primarily Treated With (Chemo)radiation: A Systematic Review

International journal of radiation oncology, biology, physics, 2011-02, Vol.79 (2), p.325-334

2011

Volltextzugriff (PDF)

Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma

Genes chromosomes & cancer, 2016-01, Vol.55 (1), p.45-59

2016

Volltextzugriff (PDF)

ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies

Biochimica et biophysica acta. Reviews on cancer, 2018-12, Vol.1870 (2), p.176-184

2018

Volltextzugriff (PDF)

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer

Oncoimmunology, 2017-09, Vol.6 (9), p.e1338230-e1338230

2017

Volltextzugriff (PDF)

CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma

European journal of cancer (1990), 2016-06, Vol.60, p.1-11

2016

Volltextzugriff (PDF)

DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population

International journal of cancer, 2021-04, Vol.148 (7), p.1768-1777

2021

Volltextzugriff (PDF)

The role of ATM and 53BP1 as predictive markers in cervical cancer

International journal of cancer, 2012-11, Vol.131 (9), p.2056-2066

2012

Volltextzugriff (PDF)

Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer

Clinical cancer research, 2017-05, Vol.23 (9), p.2213-2222

2017

Volltextzugriff (PDF)

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

Genome medicine, 2015-10, Vol.7 (1), p.108-108, Article 108

2015

Volltextzugriff (PDF)

Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer

Clinical cancer research, 2017-07, Vol.23 (14), p.3813-3822

2017

Volltextzugriff (PDF)

Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off

PloS one, 2014-07, Vol.9 (7), p.e101930-e101930

2014

Volltextzugriff (PDF)

CADM1 and MAL promoter methylation levels in hrHPV‐positive cervical scrapes increase proportional to degree and duration of underlying cervical disease

International journal of cancer, 2013-09, Vol.133 (6), p.1293-1299

2013

Volltextzugriff (PDF)

Impact of health-related behavioral factors on participation in a cervical cancer screening program: the lifelines population-based cohort

BMC public health, 2023-11, Vol.23 (1), p.2376-2376, Article 2376

2023

Volltextzugriff (PDF)

A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

Clinical cancer research, 2017-12, Vol.23 (24), p.7621-7632

2017

Volltextzugriff (PDF)

Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions

Drug resistance updates, 2016-01, Vol.24, p.55-69

2016

Volltextzugriff (PDF)

Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer

Clinical cancer research, 2011-03, Vol.17 (6), p.1317-1330

2011

Volltextzugriff (PDF)

1 – 25 von 95

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(95)

Sprache

Englisch
(95)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene

Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer

Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways

Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression

Expression of Epidermal Growth Factor Receptor (EGFR) and Activated EGFR Predict Poor Response to (Chemo)radiation and Survival in Cervical Cancer

Genome-wide promoter analysis uncovers portions of the cancer methylome

Prognostic Cell Biological Markers in Cervical Cancer Patients Primarily Treated With (Chemo)radiation: A Systematic Review

Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma

ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer

CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma

DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population

The role of ATM and 53BP1 as predictive markers in cervical cancer

Platinum-Based Chemotherapy Induces Methylation Changes in Blood DNA Associated with Overall Survival in Patients with Ovarian Cancer

HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer

Comparing the Cervista HPV HR test and Hybrid Capture 2 assay in a Dutch screening population: improved specificity of the Cervista HPV HR test by changing the cut-off

CADM1 and MAL promoter methylation levels in hrHPV‐positive cervical scrapes increase proportional to degree and duration of underlying cervical disease

Impact of health-related behavioral factors on participation in a cervical cancer screening program: the lifelines population-based cohort

A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer

Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions

Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer

Suchergebnisse filtern